Literature DB >> 2481336

Intraepithelial T cells of the TcR gamma/delta+ CD8- and V delta 1/J delta 1+ phenotypes are increased in coeliac disease.

T S Halstensen1, H Scott, P Brandtzaeg.   

Abstract

Expression of the gamma/delta T-cell receptor (TcR) for antigen on CD3+ intraepithelial lymphocytes (IEL) was studied in situ by two-colour immunofluorescence on jejunal tissue sections from 24 patients with coeliac disease and 17 controls. The proportion of intraepithelial TcR gamma/delta+ cells was significantly increased (P less than 0.002) in untreated (median 20%, range 11-53%) as well as in treated (gluten-free diet) coeliac disease (median 23%, range 16-55%) compared with controls (median 2%, range 0-39%). Although TcR alpha/beta+ IEL dominated both in controls and coeliac disease, T cells expressing the TcR gamma/delta were preferentially located within the epithelium rather than in the lamina propria. Paired staining for TcR gamma/delta and CD8 revealed that most (approximately 90%) intraepithelial TcR gamma/delta+ lymphocytes in coeliac disease were CD8-. A remarkably large fraction (median 67%, range 58-94%) of intraepithelial TcR gamma/delta+ cells expressed the V delta 1/J delta 1-encoded epitope revealed by monoclonal antibody delta TCS1. Our results suggested that increase of the intraepithelial TcR gamma/delta+ CD8- subset of T cells is particularly related to coeliac disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481336     DOI: 10.1111/j.1365-3083.1989.tb02474.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  79 in total

1.  Local challenge of oral mucosa with gliadin in patients with coeliac disease.

Authors:  H Lähteenoja; M Mäki; M Viander; A Toivanen; S Syrjänen
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 2.  Tissue distribution, antigen specificity and effector functions of gamma delta T cells in human diseases.

Authors:  G De Libero
Journal:  Springer Semin Immunopathol       Date:  2000

Review 3.  Intraepithelial lymphocytes in celiac disease immunopathology.

Authors:  Valérie Abadie; Valentina Discepolo; Bana Jabri
Journal:  Semin Immunopathol       Date:  2012-06-03       Impact factor: 9.623

Review 4.  Maturation, selection and specificity of Tcr gamma delta T cells.

Authors:  L Lefrançois
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

5.  Increase of lymphocytes bearing the gamma/delta T cell receptor in the jejunum of patients with dermatitis herpetiformis.

Authors:  E Savilahti; T Reunala; M Mäki
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

Review 6.  Ages of celiac disease: from changing environment to improved diagnostics.

Authors:  Alberto Tommasini; Tarcisio Not; Alessandro Ventura
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

7.  Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression.

Authors:  I N Farstad; F-E Johansen; L Vlatkovic; J Jahnsen; H Scott; O Fausa; A Bjørneklett; P Brandtzaeg; T S Halstensen
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

8.  Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes.

Authors:  I C Roura-Mir; L Alcalde; F Vargas; E Tolosa; G Obiols; M Foz; D Jaraquemada; R Pujol-Borrell
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

9.  T-cell receptor gamma delta-expressing intraepithelial lymphocytes are present in normal and chronically inflamed human gingiva.

Authors:  C Lundqvist; M L Hammarström
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

10.  Intraepithelial gamma/delta T cells in duodenal mucosa are related to the immune state and survival time in AIDS.

Authors:  D E Nilssen; F Müller; O Oktedalen; S S Frøland; O Fausa; T S Halstensen; P Brandtzaeg
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.